Alibaba Health, Sinovac in deal to build platform for coronavirus vaccine inoculation

Reuters2020-09-17

BEIJING/HONG KONG, Sept 17 (Reuters) - Alibaba Health Information Technology said on Thursday it has signed a strategic cooperation agreement with Chinese coronavirus vaccine developer Sinovac Biotech .

The two firms will jointly build a platform for coronavirus vaccine inoculation in the future, Alibaba Health said in Chinese social media platform Weibo, without giving further details.

Sinovac's coronavirus vaccine candidate CoronaVac, being tested in final-stage large-scale trials in Brazil, Indonesia and Turkey, has already been given to tens of thousands of people via an emergency use program China launched in July.

They include around 90% of the firm's employees and their families.

The two firms will also cooperate in broader areas including online booking of vaccines and post-vaccination health condition follow-up, Alibaba Health said.

(Reporting by Roxanne Liu in Beijing and Meg Shen in Hong Kong; Editing by Jan Harvey)

((hongkong.newsroom@thomsonreuters.com; (8610)6627-1277; Reuters Messaging: roxanne.liu@thomsonreuters.com))

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法